You are here

P&T News

December 16

Study data show test predicts risk better in black women
Authors say ERs will need to provide wider range of health-care services
Smoking remains leading cause of preventable death and disease in U.S.
Comedian Joan Rivers’ death spurs increased scrutiny

December 15

Peptide activates innate repair receptor, turns off inflammation
Combo treatment increases progression-free survival versus vemurafinib alone
Vaccine candidate stimulates production of neutralizing antibodies
Reform reduces incidence of preventable, hospital-acquired health problems

December 12

Finding could lead to new testing and treatment methods
No significant improvement in progression-free survival
Phase III data reported at neuropsychopharmacology meeting
Capecitabine/ibandronate combo no better than ibandronate alone

December 11

Expert warns of return to ‘dark ages’ of medicine
Bortezomib/fulvestrant shows promise in mid-stage trial
Researchers see no effect on walking pain of lumbar spinal stenosis

December 10

Environmental transmission can’t be discounted, researchers say
Authors identify weakness in fee-for-service medicine
Synthetic peptides inhibit bacterial growth
Investigators say they’re encouraged by the results

December 9

Mortality rate has remained steady at 30% for three decades
Authors report greater than twofold risk compared with codeine
Declaration seen as important step in effort to develop Ebola vaccines

December 8

Treatment achieves 64% complete response rate in clinical trial
Harvard scientists convert 'bad' fat to 'good' fat

December 5

Co-owner sentenced to probation; fines total $50,000
“Drift variants” reduce effectiveness of current vaccine
JAK1/JAK2 inhibitor targets overactive pathway signalling
Canadian researchers put numbers on health risk

December 4

First anti-CD19 drug to receive agency approval
Current market constrained by patent expirations of leading treatments
Medicaid and prescription drugs show modest increase

December 3

First pairing of nebulized drug and device for CF patients
Prescriptions for chronic conditions fuel epidemic, expert says
Reorganized sections provide more risk–benefit data



From Sovaldi to Ebola: A Wide-ranging Interview with Dr. David Nash

A leading authority on population health, Dr. David Nash is optimistic about the future of disruptive innovation to improve healthcare in the U.S. The interview was conducted by P&T Editor Sonja Sherritze.